US Activist Hedge Fund Institutional SEC 13D 13G — August 19, 2026

19-08-2026

Crosslink Capital, Inc., Crosslink Capital Management, LLC, and Michael J. Stark filed a Schedule 13D/A disclosing that Weave Communications, Inc. entered into a definitive merger agreement on August 18, 2026, to be acquired by affiliates of Francisco Partners Management, L.P. for $7.40 per share in cash. The Reporting Persons collectively beneficially own 5,116,426 shares (6.4% of outstanding common stock) and have entered into support agreements to vote their shares in favor of the merger. The transaction is subject to stockholder approval, antitrust clearance, and other customary closing conditions.

• · The merger agreement was entered into on August 18, 2026.
• · Crosslink and CCM entered into support agreements to vote their advised funds' shares in favor of the merger.
• · The merger is subject to adoption by majority of outstanding shares, HSR Act waiting period expiration, and no adverse governmental order.
• · Parent's obligation is also conditioned on no Company Material Adverse Effect and receipt of a payoff letter for the Issuer's credit facility.
• · No transactions in the Issuer's securities were effected by the Reporting Persons during the past sixty days.

19-08-2026

Joseph Stilwell and his affiliated funds filed a Schedule 13D/A on August 19, 2026, disclosing beneficial ownership of 2,433,708 shares of Wheeler Real Estate Investment Trust, Inc. common stock, representing approximately 49.99% of the outstanding shares. The filing reports that on August 17, 2026, the Group entered into a Third Letter Agreement Amendment and a Registration Rights Agreement with the Issuer. The Group's stated purpose is to profit from appreciation in the Issuer's securities through asserting shareholder rights, and they have not made any additional purchases since the last report.

• · The filing is the thirty-eighth amendment to the original Schedule 13D filed on July 3, 2017.
• · The Group entered into a Third Letter Agreement Amendment and a Registration Rights Agreement with the Issuer on August 17, 2026.
• · No member of the Group has been convicted in a criminal proceeding (excluding traffic violations) in the past five years.
• · Joseph Stilwell's business address is 200 Calle del Santo Cristo, Segundo Piso, San Juan, Puerto Rico 00901.
• · The Group has not expended any monies to acquire securities of the Issuer since the last report.

19-08-2026

Uber Technologies, Inc. filed an amended Schedule 13D disclosing that on August 17, 2026, its wholly-owned subsidiary Neben Holdings, LLC sold 72,000,000 shares of Aurora Innovation Class A common stock in a block sale at $6.55 per share. Following the sale, Uber beneficially owns 186,473,411 shares, representing approximately 10.9% of Aurora's outstanding Class A common stock. Uber states it may further dispose of its remaining stake depending on various factors, but is not currently engaged in discussions with Aurora's management regarding control or strategy.

• · The block sale was executed on August 17, 2026, at a price of $6.55 per share.
• · Uber's beneficial ownership dropped from a previously higher level (not specified in this filing) to 10.9% of Class A common stock.
• · Uber retains sole voting and dispositive power over all 186,473,411 shares it still holds.
• · Uber explicitly states it is not currently in discussions with Aurora's management or board regarding control, strategy, or board composition.
• · The filing lists Uber's directors and executive officers, including their citizenships (e.g., Andrew Macdonald is Canadian, Balaji Krishnamurthy is Indian, Turqi Alnowaiser is Saudi, Alexander Wynaendts is Dutch).

19-08-2026

Terry LaCore filed an amended Schedule 13G with the SEC on August 19, 2026, disclosing beneficial ownership of 159,585 shares of Mannatech Inc common stock, representing 8.27% of the outstanding shares. The filing indicates no change in control intent and was made under Rule 13d-1(c).

• · Filing is an amendment (Schedule 13G/A) to a prior beneficial ownership report.
• · The securities are common stock with par value $0.0001 per share.
• · LaCore disclaims any purpose or effect of changing or influencing control of the issuer.
• · A Limited Power of Attorney was executed on August 10, 2026, authorizing Ferguson Braswell Fraser Kubasta PC and its attorneys to make SEC filings on LaCore's behalf.

19-08-2026

Nexera Technologies Ltd disclosed beneficial ownership of 11,416,863 common shares of Fort Technology Inc, representing 72.53% of the outstanding shares as of August 19, 2026. The position includes 10,558,832 shares held directly and a warrant to purchase 858,031 shares issued in August 2025. Nexera also holds contingent rights to acquire up to an additional 3,142,858 shares upon achievement of milestones related to a prior acquisition, but is restricted by a TSX Venture Exchange undertaking from exceeding 80% ownership.

• · Nexera is restricted by a TSX Venture Exchange undertaking from acquiring or converting securities that would result in ownership exceeding 80% of Fort Technology Inc's outstanding common shares.
• · The filing is made under Rule 13d-1(d) and certifies the securities were not acquired to change or influence control of the issuer.
• · Nexera Technologies Ltd was formerly known as Jeffs' Brands Ltd (name changed September 29, 2021).

19-08-2026

Ant Group Co., Ltd. and its wholly-owned subsidiaries disclosed beneficial ownership of 123,482,500 Class A ordinary shares of DSC Holdings Ltd., representing 18.4% of the outstanding class as of June 30, 2026. The filing, made on Schedule 13G, indicates passive investment intent under Rule 13d-1(d) and covers holdings through API (Hong Kong) Investment Ltd. (88,188,400 shares, 13.2%) and Prospera Investment (Singapore) Pte. Ltd. (1,764,705 ADSs representing 35,294,100 underlying shares, 5.3%). No disposals or changes in control intent were reported.

• · The filing is a Schedule 13G (passive investment), not a 13D (active control intent).
• · Ant Group's board consists of nine individuals: Xiandong JING, Xinyi HAN, Joe TSAI, Toby Hong XU, Laura May-Lung CHA, Hongjiang ZHANG, Chong-En BAI, Xiaopeng HE, and Patrick TSANG.
• · The ownership percentage is calculated based on 670,157,244 Class A ordinary shares outstanding immediately after the issuer's offering (per Form 424B4 filed June 26, 2026).
• · No disposals or changes in beneficial ownership were reported by any of the filing entities.

19-08-2026

Futurewave Capital Solutions Ltd and its sole director Daniel M. McCabe filed a Schedule 13D disclosing beneficial ownership of 3,955,625 ordinary shares (30.8%) of Futurewave Acquisition Corp, a blank-check SPAC. The shares were acquired through founder shares (3,700,125 for $25,000) and private placement units (255,500 for $2,555,000), with the sponsor paying an aggregate of $2,580,000. The filing details standard SPAC lock-up and voting agreements but does not indicate any imminent business combination or material change in strategy.

• · HBM Group, Inc. owns 17.83% of the Sponsor, and Luminark Holdings LLC owns 10% of the Sponsor.
• · The Founder Shares are subject to a 180-day lock-up from the completion of the Initial Business Combination; Private Units are locked up for 30 days post-combination.
• · The Sponsor and insiders agreed to vote in favor of a business combination, not to redeem shares, and to waive liquidation rights on Founder and Private Shares.
• · No transactions in Ordinary Shares occurred in the past 60 days except the June 26, 2026 Private Unit purchase.

19-08-2026

Jane Street Group, LLC disclosed a 7.2% beneficial ownership stake in C3is Inc. (CISS) as of August 13, 2026, holding 937,330 shares of common stock. The filing was made under Rule 13d-1(c), indicating the shares were not acquired for the purpose of changing or influencing control of the issuer. The stake is held through subsidiaries Jane Street Capital, LLC (5.2%) and Jane Street Global Trading, LLC (2.0%).

• · The filing is a Schedule 13G, not a 13D, indicating passive investment intent.
• · Jane Street Group, LLC is a Delaware limited liability company with principal business address at 250 Vesey Street, 3rd Floor, New York, NY 10281.
• · The filing date is August 19, 2026, with the date of event being August 13, 2026.
• · The issuer, C3is Inc., is incorporated in Greece (state of incorporation: 1T) and classified under SIC 4412 (Deep Sea Foreign Transportation of Freight).

19-08-2026

L.I.A. Pure Capital Ltd. and its subsidiary Xylo Technologies Ltd. filed a Schedule 13G/A disclosing aggregate beneficial ownership of 9.99% of Quantum X Labs Inc. (formerly Viewbix Inc.) common stock as of June 30, 2026. The filing includes 2,179,600 shares held directly and warrants exercisable within 60 days, subject to a 4.99% blocker provision. Xylo Technologies Ltd. separately holds 315,066 shares (1.44%), and L.I.A. Pure Capital disclaims beneficial ownership of Xylo's shares except to the extent of its pecuniary interest.

• · The filing is an amendment (Schedule 13G/A) filed under Rule 13d-1(c).
• · L.I.A. Pure Capital Ltd. is the parent of Xylo Technologies Ltd.
• · Pure Capital's beneficial ownership includes 1,727,817 shares held directly and 136,717 shares from a warrant exercisable within 60 days, but excludes 1,292,998 shares from a pre-funded warrant and 450,000 shares from another warrant due to a 4.99% blocker provision.
• · The filing certifies that the securities were not acquired to change or influence control of the issuer.

19-08-2026

Pelican II Capital Solutions Ltd filed a Schedule 13D disclosing beneficial ownership of 3,186,500 ordinary shares (26.36%) of Pelican Acquisition II Corp as of July 27, 2026. The sponsor acquired 2,875,000 founder shares for $25,000 and 311,500 private placement units at $10.00 per unit in connection with the issuer's IPO. The filing outlines lock-up, voting, and waiver agreements related to the blank-check company's initial business combination, but no business combination target has been announced.

• · The sponsor has sole voting and dispositive power over all 3,186,500 ordinary shares.
• · The sponsor agreed to vote its shares in favor of any initial business combination, waive redemption rights, and waive liquidation distributions if no business combination is completed within 21 months of the IPO.
• · No transactions in the issuer's ordinary shares were effected by the reporting person during the 60 days preceding the filing date.
• · The issuer is a blank check company formed for the purpose of effecting a merger or similar business combination.

19-08-2026

OceanLight Capital Sponsor Ltd. disclosed ownership of 5,144,750 ordinary shares (33.53%) of OceanLight Acquisition Corp in a Schedule 13D filing on August 19, 2026, following the SPAC's IPO on August 10, 2026. The Sponsor acquired 4,933,500 founder shares for $25,000 and 211,250 private placement units for $10.00 per unit. Up to 643,500 founder shares remain subject to forfeiture depending on underwriters' over-allotment exercise, and the sponsor has agreed to vote in favor of an initial business combination and waive certain redemption rights, but no target business combination has been announced yet.

• · The filing is a Schedule 13D (not a 13G), indicating active intent to influence or control the issuer.
• · HBM Group, Inc. owns 17.63% of the Sponsor, and Luminark Holdings LLC owns 10%.
• · The Sponsor's founder shares are subject to a 180-day lock-up following a business combination, and private units are locked for 30 days post-combination.
• · The Sponsor has waived redemption rights and rights to liquidating distributions from the trust account with respect to founder shares if no business combination is completed within the specified period.
• · The underwriters' over-allotment option has not been exercised as of the filing date.
• · No transactions in ordinary shares by the Sponsor occurred during the 60 days prior to the filing.

19-08-2026

Point72 Asset Management, L.P., together with Point72 Capital Advisors, Inc. and Steven A. Cohen, disclosed a 6.0% beneficial ownership stake in RxSight, Inc. as of August 18, 2026, holding 2,487,468 shares of common stock. The filing, made under Rule 13d-1(c), indicates the shares are held through Point72 Associates, LLC and certifies that the securities were not acquired with the purpose of changing or influencing control of the issuer.

• · The filing was made pursuant to Rule 13d-1(c), an exemption for passive investors.
• · Point72 entities own no shares directly; all 2,487,468 shares are held through Point72 Associates, LLC.
• · The joint filing agreement was signed by Jason M. Colombo as authorized person for all reporting entities.

19-08-2026

Saba Capital Management, L.P., along with Saba Capital Management GP, LLC and Boaz R. Weinstein, disclosed a 5.11% beneficial ownership stake in AVAX One Technology Ltd. (formerly Agriforce Growing Systems Ltd.) as of August 13, 2026. The stake comprises 378,025 common shares, based on 7,397,383 shares outstanding. The filing is a Schedule 13G under Rule 13d-1(c), indicating passive investment intent.

• · The filing is made pursuant to Rule 13d-1(c), indicating passive investment intent.
• · The reporting persons have entered into a Joint Filing Agreement dated August 19, 2026.
• · The company was formerly known as Agriforce Growing Systems Ltd. and changed its name on September 28, 2020.
• · The business address of the reporting persons is 405 Lexington Avenue, 58th Floor, New York, NY 10174.

19-08-2026

Strategic Value Investors LP and related entities filed a Schedule 13G/A with the SEC, disclosing a 3.9% beneficial ownership stake in SB Financial Group, Inc. as of June 30, 2026, representing 243,628 shares of common stock. The filing confirms the shares were acquired and are held in the ordinary course of business, not for changing or influencing control of the issuer.

• · The filing is an amendment (Schedule 13G/A) filed on August 19, 2026, with a date of change of August 19, 2026.
• · The beneficial ownership is passive under Rule 13d-1(b), indicating no intent to control the issuer.
• · Each reporting person disclaims beneficial ownership except to the extent of their pecuniary interest.
• · Strategic Value Investors LP is a Delaware limited partnership; Strategic Value Bank Partners LLC and Strategic Value Private Partners LLC are Ohio limited liability companies.

19-08-2026

YR Sea Group Pte. Ltd. and Junwu Hu filed a Schedule 13G with the SEC on August 19, 2026, disclosing beneficial ownership of 264,368 ordinary shares of iOThree Ltd (IOTR), representing 8.72% of the 3,032,199 shares outstanding as of July 20, 2026. The filing is a passive investment disclosure under Rule 13d-1(c), indicating the shares were not acquired to influence control of the issuer.

• · The filing is made under Rule 13d-1(c), confirming a passive investment intent.
• · Both reporting persons share the same business address: 9 Temasek Boulevard, #06-02, Suntec Tower Two, Singapore 038989.
• · Junwu Hu is a director of YR Sea Group Pte. Ltd. and signed the filing on behalf of both entities.
• · A Joint Filing Agreement was executed between Junwu Hu and YR Sea Group Pte. Ltd. on August 19, 2026.

19-08-2026

Pertento Partners LLP, Pertento Advisors LLC, and Eduardo Marques filed a Schedule 13G disclosing beneficial ownership of 5,502,115 shares of Grocery Outlet Holding Corp. common stock, representing a 5.6% stake. The filing is a passive investment disclosure under Rule 13d-1(c), with no intent to influence control of the issuer. No prior period comparison is available as this is an initial filing.

• · The shares are held directly by advisory clients of Pertento Partners LLP and Pertento Advisors LLC; none of those clients individually beneficially own more than 5% of the class.
• · Each reporting person disclaims beneficial ownership except for pecuniary interest.
• · The filing is made pursuant to Rule 13d-1(c), indicating a passive investment intent.
• · The filing date is August 19, 2026, with the event triggering date of August 13, 2026.

19-08-2026

Warburg Pincus LLC and affiliated funds filed an amended Schedule 13D disclosing aggregate beneficial ownership of 9,574,639 shares of OceanFirst Financial Corp. common stock, representing 9.9% of shares outstanding as of August 3, 2026. The filing also reveals that WPGG14 Investor entered into a margin loan agreement on August 17, 2026, borrowing $61.5 million secured by a pledge of 6,415,008 shares and 1,214 NVCE Stock. No transactions in the common stock were reported in the past 60 days.

• · The margin loan matures on or about July 31, 2028.
• · Lenders may require prepayment or additional collateral upon customary events, and may foreclose on pledged shares.
• · No transactions in common stock were effected by the reporting persons in the past 60 days.
• · The filing amends the original Schedule 13D filed on June 8, 2026.

19-08-2026

ISQ Global Fund II GP LLC and related reporting persons filed Amendment No. 15 to their Schedule 13D, disclosing beneficial ownership of 18,098,785 shares of Kinetik Holdings Inc. Class A Common Stock, representing approximately 18.9% of the outstanding shares. The filing details a redemption of 1,500,000 Common Units by Buzzard Midstream LLC on July 29, 2026, and a series of open-market sales of Class A Common Stock by Buzzard Midstream LLC in August 2026, totaling approximately 1,000,000 shares sold at weighted average prices ranging from $50.04 to $54.84. The reporting persons continue to hold a significant stake, but the recent sales indicate a reduction in their position.

• · The reporting persons disclaim being part of a 'group' with Blackstone, Apache, or their affiliates.
• · All transactions in the past 60 days were sales by Buzzard Midstream LLC in the open market; no purchases were reported.
• · The largest single sale was 210,552 shares on August 6, 2026 at a weighted average price of $50.4619.
• · The highest weighted average sale price was $54.8396 for 6 shares on August 18, 2026.
• · The reporting persons have shared voting and dispositive power over all 18,098,785 shares.

19-08-2026

General Atlantic entities filed an amended Schedule 13D with the SEC on August 19, 2026, disclosing that on August 17, 2026, General Atlantic DO B.V. sold 9,842,559 Class A common shares of dLocal Ltd in open market transactions at an average price of $13.60 per share. Following the sale, the General Atlantic group continues to beneficially own 36,814,136 Class A common shares, representing approximately 21.4% of the outstanding shares, based on 172,183,455 shares outstanding as of June 30, 2026.

• · The filing is Amendment No. 3 to Schedule 13D, originally filed March 23, 2023.
• · The sale occurred on August 17, 2026, within 60 days of the filing date.
• · The group includes 21 reporting persons, with General Atlantic, L.P. as the lead filer.
• · The GA Partnership Committee, consisting of six members, controls investment decisions for the group.
• · No other transactions in Class A common shares were reported by the group in the past 60 days aside from the disclosed sale.

19-08-2026

Daniel Louis Kaufman has reported a 5.9% beneficial ownership stake in Stereotaxis, Inc., holding 5,956,714 shares of common stock as of August 12, 2026. The filing is a Schedule 13G, indicating a passive investment position, and the ownership percentage is based on 100,202,178 shares outstanding as of July 31, 2026.

• · The filing is made under Rule 13d-1(c), indicating a passive investor status.
• · Kaufman has sole voting and dispositive power over all 5,956,714 shares.
• · The shares are held directly by Daniel Louis Kaufman.

19-08-2026

Millennium Management LLC, together with Millennium Group Management LLC and Israel A. Englander, disclosed a 5.5% beneficial ownership stake in T1 Energy Inc. (formerly FREYR Battery, Inc.) as of August 14, 2026, holding 16,269,184 shares of common stock. The filing is a Schedule 13G submitted under Rule 13d-1(c), indicating passive investment intent with no aim to change or influence control of the issuer.

• · The filing was made under Rule 13d-1(c), confirming the shares were not acquired with the purpose of changing or influencing control of the issuer.
• · The entities disclaim beneficial ownership of securities held by other entities under their control, as noted in the filing.
• · A Joint Filing Agreement was executed on August 18, 2026, among Millennium Management LLC, Millennium Group Management LLC, and Israel A. Englander.

19-08-2026

William T. Walters, Susan B. Walters, and their affiliated entity The Walters Group filed a Schedule 13G/A with the SEC reporting beneficial ownership of 17,844,973 shares of Zentalis Pharmaceuticals, Inc. common stock, representing an 18.8% stake in the company as of August 14, 2026. The filing indicates a substantial passive stake in the clinical-stage pharmaceutical company, with no intention to change or influence control of the issuer.

• · The filing is an amendment (Schedule 13G/A) under Rule 13d-1(c), indicating a passive investor status.
• · William T. Walters is listed as a U.S. citizen; Susan B. Walters is also a U.S. citizen.
• · The Walters Group was organized as a Nevada general partnership.
• · The shares outstanding figure (94,668,568) is based on Zentalis's Prospectus on Form 424B5 filed on August 14, 2026.

19-08-2026

William John Vencl Jr. filed a Schedule 13G with the SEC on August 19, 2026, disclosing beneficial ownership of 1,509,172 shares of Tidal Trust II, representing a 6.2% stake. The filing indicates the shares were acquired and are held for investment purposes, not to influence control of the issuer.

• · Filing made under Rule 13d-1(c) (passive investor exemption).
• · Vencl has sole voting and dispositive power over all 1,509,172 shares.
• · The filing date is August 19, 2026, with event date of August 17, 2026.

19-08-2026

Millennium Management LLC, along with Millennium Group Management LLC and Israel A. Englander, filed a Schedule 13G with the SEC on August 19, 2026, disclosing beneficial ownership of 3,376,401 shares of Vanda Pharmaceuticals Inc. common stock. This position represents a 5.6% stake in the company as of August 17, 2026. The filing is a passive investment disclosure under Rule 13d-1(c), indicating the shares were not acquired to influence or change control of Vanda.

• · The filing was made under Rule 13d-1(c), indicating a passive investment intent.
• · The filing date is August 19, 2026, with the event date of beneficial ownership being August 17, 2026.
• · The joint filing agreement includes Millennium Management LLC, Millennium Group Management LLC, and Israel A. Englander.
• · The CUSIP number for Vanda Pharmaceuticals common stock is 921659108.

19-08-2026

Enavate Sciences GP, LLC and its affiliate Zebra Aggregator, LP filed an amended Schedule 13D with the SEC on August 19, 2026, disclosing that they sold 673,755 shares of Zenas BioPharma common stock in an open market sale at an average price of $31.44 per share. Following this transaction, the reporting persons' beneficial ownership dropped to 4.98% of the outstanding common stock (based on 65,176,723 shares outstanding as of July 31, 2026), falling below the 5% threshold.

• · The filing is Amendment No. 2 to the original Schedule 13D filed on September 23, 2024, and amended on October 14, 2025.
• · The reporting persons ceased to be beneficial owners of more than 5% of the common stock on August 19, 2026.
• · No other person is known to have the right to receive or direct the receipt of dividends or proceeds from the sale of the common stock.
• · The transaction was an open market sale of 673,755 shares at a weighted average price of $31.44 per share, with prices ranging from $31.05 to $32.00.

19-08-2026

Jorey Chernett filed a Schedule 13G/A with the SEC on August 19, 2026, disclosing beneficial ownership of 2,339,009 American Depositary Shares (ADS) of Kazia Therapeutics Ltd, representing 19.6% of the company's outstanding ADS. The filing indicates a passive investment intent, with no purpose or effect of changing or controlling the issuer.

• · The filing is an amendment (13G/A) to a previously filed Schedule 13G.
• · The securities were acquired and are held for passive investment purposes, not to influence control of the issuer.
• · Jorey Chernett's principal business address is 6222 Indianwood Trail, Bloomfield Hills, MI 48301.
• · The filing was made pursuant to Rule 13d-1(c) under the Securities Exchange Act of 1934.

19-08-2026

Winklevoss entities (Winklevoss Capital Fund, Winklevoss Treasury Investments, and principals Tyler and Cameron Winklevoss) filed an amended Schedule 13D on August 19, 2026, disclosing a 19.9% beneficial ownership stake in Cypherpunk Technologies Inc. The filing details two key transactions on August 17, 2026: (1) the exercise of Pre-Funded Warrants for 16,570,852 shares at $0.001 per share, and (2) an Asset Purchase Agreement (APA) where Cypherpunk's subsidiary acquired mining assets from Moria Mining, LLC for $33,333,333, paid via a pre-funded warrant for 43,290,042 shares issued to Winklevoss Treasury Investments. The filing notes that the Winklevoss group is currently prohibited from exercising additional warrants due to a 19.99% beneficial ownership limitation, pending stockholder approval at the next annual meeting.

• · The Winklevoss group's beneficial ownership is capped at 19.9% due to a Beneficial Ownership Limitation in the warrants, preventing exercise beyond that threshold.
• · The APA Pre-Funded Warrant has an exercise price of $0.001 per share and is exercisable at any time, subject to the 19.99% ownership limitation.
• · Cypherpunk Technologies must seek stockholder approval at its next annual meeting to allow issuance of Warrant Shares exceeding 5,377,442 (4.99% of pre-signing outstanding shares).
• · Winklevoss Treasury Investments is required to vote its shares in favor of the Stockholder Proposal.
• · The filing amends a prior Schedule 13D originally filed on October 16, 2025, and amended on November 21, 2025.

19-08-2026

Millennium Management LLC, together with Millennium Group Management LLC and Israel A. Englander, filed a Schedule 13G disclosing beneficial ownership of 2,857,387 shares of Capricor Therapeutics, Inc. common stock, representing 4.9% of the outstanding shares. The filing indicates that the reporting persons crossed above the 5% threshold on August 17, 2026, but subsequently fell back below 5% by the filing date, resulting in a passive stake just under the reporting threshold.

• · The filing is made pursuant to Rule 13d-1(c), indicating a passive investment intent.
• · The reporting persons certify that the securities were not acquired with the purpose of changing or influencing control of the issuer.
• · A Joint Filing Agreement dated August 18, 2026, was executed among the reporting persons.

19-08-2026

Polaris Management Co. VII, L.L.C. and affiliated entities filed an amended Schedule 13D with the SEC on August 19, 2026, reporting a decrease in their aggregate ownership percentage in Camp4 Therapeutics Corp due to dilution from the company's issuance of additional shares. The filing shows that the Polaris group collectively holds approximately 4.8% of Camp4's outstanding common stock, down from a previously higher percentage, with Amir Nashat, a board member, deemed to beneficially own 6.3% of shares.

• · The filing is an amendment to the original Schedule 13D filed October 22, 2024, as amended on September 11, 2025.
• · The decrease in ownership percentage is solely due to dilution from the issuer's sale of additional shares, not from any sale of shares by the reporting persons.
• · Amir Nashat is a member of Camp4's board of directors and holds an interest in Polaris Partners GP X, L.L.C.

19-08-2026

Moringa Sponsor, LP and affiliated entities reported beneficial ownership of 1,391,827 ordinary shares of Silexion Therapeutics Corp, representing 10.6% of the outstanding shares as of the filing. However, Moringa Sponsor explicitly disputes the validity of nearly all of the shares reported (1,391,790 out of 1,391,827), claiming they were issued through disputed conversions under the Amended and Restated Promissory Note. On June 22, 2026, Moringa Sponsor filed a claim against Silexion and two senior officers alleging systematic breaches of the Note, seeking to void the conversions and demand immediate repayment, highlighting an ongoing legal dispute.

• · Moringa Sponsor, LP filed a claim on June 22, 2026 against Silexion and two senior officers alleging systematic breaches of the promissory note.
• · The disputed conversions include shares issued at varying prices: $2.2553, $1.714, $2.19, and $0.65 per share between July 30 and August 12, 2026.
• · Three reverse stock splits occurred: 1-for-9 on November 27, 2024; 1-for-15 on July 28, 2025; 1-for-10 on May 28, 2026.
• · The reporting persons explicitly disclaim beneficial ownership of all disputed shares (1,391,790 of 1,391,827 shares reported).

19-08-2026

NorthView Sponsor I, LLC and its managers Jack Stover and Fred Knechtel filed a Schedule 13D disclosing beneficial ownership of approximately 49.9% of Profusa, Inc.'s common stock following a debt-to-equity conversion. On August 12, 2026, the Sponsor converted $1,292,521 of principal into 1,207,965 shares at $1.07 per share, which were then reduced to 301,991 shares after a 1-for-4 reverse stock split. The filing highlights significant insider ownership concentration, with Stover and Knechtel each holding roughly 49.9% of the outstanding shares.

• · The promissory note was originally issued on April 27, 2023, with an original principal amount of up to $2,500,000, and was amended multiple times.
• · The conversion agreement was amended on April 29, 2026, July 31, 2026, and August 12, 2026.
• · The Sponsor is a holding company with no material business operations following the Issuer's IPO.
• · No transactions in the common stock were effected by the reporting persons in the past 60 days other than the conversion described.

19-08-2026

3i, LP and affiliated entities filed an amended Schedule 13D disclosing beneficial ownership of 2,050,200 shares of Valion Bio, Inc. (formerly Tivic Health Systems, Inc.), representing 9.9% of the outstanding common stock. The filing details a series of recent conversions of preferred stock and a new $1.5 million investment on August 17, 2026, under which 3i, LP received 1,500 shares of Series B Preferred Stock and warrants to purchase 1,153,847 shares. However, the filing also reveals that 3i, LP sold 2,770,592 shares of common stock between August 17-19, 2026 at declining prices ($0.1798 to $0.1269 per share), indicating active trading and potential dilution concerns.

• · The company changed its name from Tivic Health Systems, Inc. to Valion Bio, Inc. (date of name change: September 10, 2019).
• · 3i, LP sold 927,850 shares on August 17, 2026 at $0.1798 per share; 847,064 shares on August 18, 2026 at $0.1622 per share; and 995,678 shares on August 19, 2026 at $0.1269 per share.
• · The conversion price for Series C Preferred Stock converted on August 17, 2026 was $0.39 per share.
• · The warrant exercise price is $0.23708 per share.
• · The Issuer and 3i, LP are continuing to negotiate additional tranches of funding, but no definitive agreements are in place.

19-08-2026

Todd W. Fennell filed a Schedule 13G/A with the SEC, disclosing beneficial ownership of 5,248,846 ordinary shares of Prothena Corp Public Ltd Co, representing approximately 10.22% of the company's outstanding shares as of August 18, 2026. The shares are held in various trusts for which Fennell serves as independent trustee, and he disclaims beneficial ownership of shares in which he has no pecuniary interest.

• · The filing is an amendment (Schedule 13G/A) to a previous beneficial ownership report.
• · Fennell's address is 979 Beachland Boulevard, Vero Beach, Florida 32963.
• · The filing is made under Rule 13d-1(c), indicating passive investment intent.
• · Fennell certifies the securities were not acquired to change or influence control of the issuer.
• · A Limited Power of Attorney dated September 9, 2025, authorizes Diana L. Hayes to sign on Fennell's behalf.

19-08-2026

Pictet Asset Management SA filed a Schedule 13D/A disclosing beneficial ownership of 5,887,646 shares of Fortune Brands Innovations, Inc. (FBIN), representing 4.93% of the outstanding common stock. The filing details extensive selling activity in August 2026, with over 500,000 shares sold at prices ranging from $45.55 to $52.21, alongside smaller purchases. Pictet states it is actively engaging with the issuer to promote long-term shareholder value but does not currently seek a change in control.

• · Pictet Asset Management SA has sole voting power over 5,660,699 of the 5,887,646 shares held.
• · The filing includes extensive transaction data from June to August 2026, with significant selling on August 18, 2026 (over 336,000 shares sold at $45.55-$45.78) and June 29, 2026 (over 920,000 shares sold at $49.23-$50.42).
• · Pictet states it does not have any derivative positions, options, or other financial instruments related to FBIN securities.
• · The reporting person acquired shares on behalf of institutional clients on a discretionary basis and has no direct economic interest in dividends or sale proceeds beyond management fees.

19-08-2026

Imperial Vision Fund SPC Series 1 SP filed an amended Schedule 13G reporting that it ceased to be a beneficial owner of Dreamland Ltd as of August 13, 2026, following the sale of 320,000 Class A ordinary shares pursuant to a Sale and Purchase Agreement dated August 6, 2026. The fund now holds 0% of Dreamland's outstanding ordinary shares, down from a prior undisclosed stake.

• · The sale was executed under a Sale and Purchase Agreement dated August 6, 2026.
• · The filing is an amendment (Schedule 13G/A) indicating a change in prior ownership status.
• · The fund certifies the securities were not acquired or held to influence control of the issuer.

19-08-2026

ATLAS Infrastructure Partners (UK) Ltd. and its parent GIP Atlas Holdings Limited filed an amended Schedule 13G on August 19, 2026, disclosing beneficial ownership of 4,615,265 shares of H2O America (HTO) common stock, representing 11.03% of the outstanding shares. The amendment corrects the filing basis from Rule 13d-1(c) to Rule 13d-1(b), indicating the securities were acquired in the ordinary course of business and not to influence control. The filing confirms a significant passive stake in the water utility company.

• · The filing corrects a prior error in the filer's designation under Rule 13d-1; prior filings incorrectly selected Rule 13d-1(c) instead of Rule 13d-1(b).
• · GIP Atlas Holdings Limited holds 100% of the equity interests in ATLAS Infrastructure Partners (UK) Ltd. but does not exercise investment discretion over the entity.
• · The filer certifies the securities were acquired in the ordinary course of business and not to change or influence control of the issuer.
• · The filing date is August 19, 2026, and the date as of change is also August 19, 2026.

19-08-2026

CVI Investments, Inc. and its investment manager Heights Capital Management, Inc. filed a Schedule 13G disclosing beneficial ownership of 24,713,908 shares of Outlook Therapeutics, Inc. common stock, representing 9.9% of the 242,672,554 shares outstanding as of August 14, 2026. The reported holdings include 20,000,000 shares and shares issuable upon exercise of warrants, subject to a 9.99% ownership blocker. The filing indicates passive investment intent under Rule 13d-1(c).

• · The filing is made under Rule 13d-1(c), indicating passive investment intent.
• · Warrants are subject to a 9.99% beneficial ownership blocker.
• · Heights Capital Management serves as investment manager to CVI Investments and may be deemed beneficial owner of all shares owned by CVI.
• · The Schedule 13G was filed on August 19, 2026, with a date of event of August 12, 2026.

19-08-2026

FMR LLC and Abigail P. Johnson filed Amendment No. 23 to their Schedule 13D, reporting beneficial ownership of 3,082,424.467 common shares (52.164%) of Fidelity Multi-Strategy Credit Fund as of August 17, 2026. The filing reflects a routine increase in holdings through the Dividend Reinvestment Plan (DRP), with 11,693.83 shares acquired on July 31, 2026 at $10.28 per share. This is the 23rd amendment to the original filing, indicating ongoing, incremental accumulation rather than a material change in control or strategy.

• · The filing is Amendment No. 23 to the original Schedule 13D filed May 26, 2023.
• · DRP acquisitions on July 31, 2026 included: Class A (43.940 shares), Class C (35.424 shares), Class I (11,573.410 shares), and Class L (41.058 shares).
• · FMR Reporters have sole power to vote and dispose of all 3,082,424.467 shares.
• · No other person has the right to receive dividends or proceeds from the sale of these securities.

19-08-2026

Alta Partners LLC disclosed a 8.4% beneficial ownership stake in Biovie Inc. (BIVIW) as of August 12, 2026, consisting of 687,321 shares of Class A Common Stock issuable upon exercise of warrants. The filing is a Schedule 13G submitted under Rule 13d-1(c), indicating the shares were acquired passively and not with the intent to influence control of the issuer.

• · The filing is a Schedule 13G, not a 13D, indicating passive investment intent.
• · Alta Partners LLC is based in New York and has a business address in Old Brookville, NY.
• · The shares are held directly by Alta Partners LLC, with sole voting and dispositive power over all 687,321 shares.
• · The filing date is August 19, 2026, and the event date triggering the filing is August 12, 2026.